CoChat

Programming of macrophages by UV-irradiated apoptotic cancer cells inhibits cancer progression and lung metastasis

Open access
Kim, Yong-Bae, Ahn, Young-Ho, Jung, Ji-Hae, Lee, Ye-Ji, Lee, Jin-Hwa, Kang, Jihee Lee · 2019 · Cellular & Molecular Immunology

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Apoptotic cell clearance by phagocytes is essential in tissue homeostasis. We demonstrated that conditioned medium (CM) from macrophages exposed to apoptotic cancer cells inhibits the TGFβ1-induced epithelial–mesenchymal transition (EMT), migration, and invasion of cancer cells. Apoptotic 344SQ (ApoSQ) cell-induced PPARγ activity in macrophages increased the levels of PTEN, which was secreted in exosomes. Exosomal PTEN was taken up by recipient lung cancer cells. ApoSQ-exposed CM from PTEN knockdown cells failed to enhance PTEN in 344SQ cells, restore cellular polarity, or exert anti-EMT and anti-invasive effects. The CM that was deficient in PPARγ ligands, including 15-HETE, lipoxin A4, and 15d-PGJ 2 , could not reverse the suppression of PPARγ activity or the PTEN increase in 344SQ cells and consequently failed to prevent the EMT process. Moreover, a single injection of ApoSQ cells inhibited lung metastasis in syngeneic immunocompetent mice with enhanced PPARγ/PTEN signaling both in tumor-associated macrophages and in tumor cells. PPARγ antagonist GW9662 reversed the signaling by PPARγ/PTEN; the reduction in EMT-activating transcription factors, such as Snai1 and Zeb1 ; and the antimetastatic effect of the ApoSQ injection. Thus, the injection of apoptotic lung cancer cells may offer a new strategy for the prevention of lung metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41423-019-0209-1

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The interaction between macrophages and UV-irradiated apoptotic lung cancer cells inhibits EMT, migration, and invasion in cancer cells. a, b, e–h RAW cells were stimulated with apoptotic (ApoSQ) or necrotic (NecSQ) 344SQ cells for 24 h. c Mouse bone marrow-derived macrophages (BMDMs) (left) or M2-like BMDMs (right) were stimulated with ApoSQ or NecSQ. d Blood monocyte-derived macrophages (MDMs) from healthy donors (left) or lung cancer patients (right) were stimulated with apoptotic (ApoA) or necrotic (NecA) A549 cells for 24 h. Conditioned medium (CM) was added to 344SQ cells, shown in (a–c, e–h), or A549 cells, shown in (d), with or without TGF-β1 (10 ng/ml) for 48 h. a Morphological changes in cells were examined by phase-contrast microscopy. b–d Immunoblot analysis of indicated proteins in whole-cell lysates. e Gene expression in 344SQ cell samples was measured by real-time PCR. The quantification of migrated cells in Boyden chambers is shown in (f), and that of invaded cells in Boyden chambers is shown in (g). h 344SQ cells were cultured for 7 days in Matrigel before exposure to CM with TGF-β1 (10 ng/ml) for 72 h and photographed by phase-contrast microcopy. *P < 0.05, **P < 0.01, and ***P < 0.001. Data are from one experiment representative of three independent experiments, as shown in (a–c, h); of three donors, as shown in (d); with similar results; or from three independent experiments (mean ± s.e.m. in (e–g). Scale bars: 100 μm in (a, h)
Fig. 1 The interaction between macrophages and UV-irradiated apoptotic lung cancer cells inhibits EMT, migration, and invasion in cancer cells. a, b, e–h RAW cells were stimulated with apoptotic (ApoSQ) or necrotic (NecSQ) 344SQ cells for 24 h. c Mouse bone marrow-derived macrophages (BMDMs) (left) or M2-like BMDMs (right) were stimulated with ApoSQ or NecSQ. d Blood monocyte-derived macrophages (MDMs) from healthy donors (left) or lung cancer patients (right) were stimulated with apoptotic (ApoA) or necrotic (NecA) A549 cells for 24 h. Conditioned medium (CM) was added to 344SQ cells, shown in (a–c, e–h), or A549 cells, shown in (d), with or without TGF-β1 (10 ng/ml) for 48 h. a Morphological changes in cells were examined by phase-contrast microscopy. b–d Immunoblot analysis of indicated proteins in whole-cell lysates. e Gene expression in 344SQ cell samples was measured by real-time PCR. The quantification of migrated cells in Boyden chambers is shown in (f), and that of invaded cells in Boyden chambers is shown in (g). h 344SQ cells were cultured for 7 days in Matrigel before exposure to CM with TGF-β1 (10 ng/ml) for 72 h and photographed by phase-contrast microcopy. *P < 0.05, **P < 0.01, and ***P < 0.001. Data are from one experiment representative of three independent experiments, as shown in (a–c, h); of three donors, as shown in (d); with similar results; or from three independent experiments (mean ± s.e.m. in (e–g). Scale bars: 100 μm in (a, h)CC BY · PubMed Central
Fig. 2 PPARγ-dependent PTEN secretion in exosomes and PTEN uptake by recipient cells. qPCR analysis of PPARγ and PTEN mRNA in RAW cells exposed to apoptotic 344SQ cells (ApoSQ) for the indicated times shown in (a, b) or PTEN mRNA in blood MDMs from healthy donors or lung cancer patients exposed to apoptotic (ApoA) or necrotic (NecA) A549 cells for 24 h, as shown in (c). d Immunoblot analysis of indicated proteins in RAW cells transfected with PPARγ siRNA before ApoSQ stimulation for 24 h. e Immunoblot analysis of indicated proteins in BMDMs (left) or M2-like BMDMs (right) pretreated with GW9662 (10 μM) for 1 h before stimulation with ApoSQ for 24 h. f Immunoblot analysis of PTEN with whole-cell lysates from mouse BMDMs stimulated with ApoSQ (WCL) and of the secretion levels of PTEN using affinity pull-down in conditioned medium (CM). PTEN immunoprecipitates were separated by SDS-PAGE in nonreducing conditions. The arrows indicate the immunoglobulin heavy/light chain complex (up) and PTEN (down). g CM from RAW cells pretreated with 10 μM of GW9662 before ApoSQ stimulation for 24 h was fractionated by ultracentrifugation, and the soluble (sol) and insoluble (ins) fractions were immunoblotted with antibodies against PTEN, CD63, CD81, or CD9. h TEM images of exosomes isolated from the CM of ApoSQ-stimulated RAW cells pretreated with or without 20 μM GW4869. Scale bars: 20 μm. i Size distribution analysis of exosomes from the CM of ApoSQ-stimulated RAW cells pretreated with 20 μM GW4869 or vehicle (2% DMSO in saline). The horizontal axis represents particle size (nm), and the vertical axis represents particle concentration (×106 particles/ml). The red bars represent the s.e.m. The values represent the mode or mean size ± s.e.m. from three independent experiments. j Immunoblot analysis of GFP-PTEN, CD63, CD81, and CD9 in the soluble and insoluble fractions after ultracentrifugation of CM from a human macrophage cell line (hMϕ) overexpressing GFP-PTEN exposed to ApoA. k Direct fluorescence of 344SQ and A549 cells 24 h after treatment with harvested exosomes containing GFP-PTEN using confocal microcopy. Scale bars: 20 μm. l Lysates from 344SQ and A549 cells after incubation with harvested exosomes from hMϕ overexpressing GFP-PTEN were subjected to western blotting analysis. NS not significant; **P < 0.01 and ***P < 0.001. Data are from three independent experiments (mean ± s.e.m. in (a, b, i) below tables), three donors (mean ± s.e.m. in (c)), or one experiment representative of three independent experiments with similar results, as shown in (d–l)
Fig. 2 PPARγ-dependent PTEN secretion in exosomes and PTEN uptake by recipient cells. qPCR analysis of PPARγ and PTEN mRNA in RAW cells exposed to apoptotic 344SQ cells (ApoSQ) for the indicated times shown in (a, b) or PTEN mRNA in blood MDMs from healthy donors or lung cancer patients exposed to apoptotic (ApoA) or necrotic (NecA) A549 cells for 24 h, as shown in (c). d Immunoblot analysis of indicated proteins in RAW cells transfected with PPARγ siRNA before ApoSQ stimulation for 24 h. e Immunoblot analysis of indicated proteins in BMDMs (left) or M2-like BMDMs (right) pretreated with GW9662 (10 μM) for 1 h before stimulation with ApoSQ for 24 h. f Immunoblot analysis of PTEN with whole-cell lysates from mouse BMDMs stimulated with ApoSQ (WCL) and of the secretion levels of PTEN using affinity pull-down in conditioned medium (CM). PTEN immunoprecipitates were separated by SDS-PAGE in nonreducing conditions. The arrows indicate the immunoglobulin heavy/light chain complex (up) and PTEN (down). g CM from RAW cells pretreated with 10 μM of GW9662 before ApoSQ stimulation for 24 h was fractionated by ultracentrifugation, and the soluble (sol) and insoluble (ins) fractions were immunoblotted with antibodies against PTEN, CD63, CD81, or CD9. h TEM images of exosomes isolated from the CM of ApoSQ-stimulated RAW cells pretreated with or without 20 μM GW4869. Scale bars: 20 μm. i Size distribution analysis of exosomes from the CM of ApoSQ-stimulated RAW cells pretreated with 20 μM GW4869 or vehicle (2% DMSO in saline). The horizontal axis represents particle size (nm), and the vertical axis represents particle concentration (×106 particles/ml). The red bars represent the s.e.m. The values represent the mode or mean size ± s.e.m. from three independent experiments. j Immunoblot analysis of GFP-PTEN, CD63, CD81, and CD9 in the soluble and insoluble fractions after ultracentrifugation of CM from a human macrophage cell line (hMϕ) overexpressing GFP-PTEN exposed to ApoA. k Direct fluorescence of 344SQ and A549 cells 24 h after treatment with harvested exosomes containing GFP-PTEN using confocal microcopy. Scale bars: 20 μm. l Lysates from 344SQ and A549 cells after incubation with harvested exosomes from hMϕ overexpressing GFP-PTEN were subjected to western blotting analysis. NS not significant; **P < 0.01 and ***P < 0.001. Data are from three independent experiments (mean ± s.e.m. in (a, b, i) below tables), three donors (mean ± s.e.m. in (c)), or one experiment representative of three independent experiments with similar results, as shown in (d–l)CC BY · PubMed Central
Fig. 3 Internalized PTEN alters signaling, retains polarity, and inhibits the EMT and invasion of 344SQ cells. a Immunoblot analysis of indicated proteins in 344SQ cell lysates after incubation with CM for the indicated times. b Immunoblot analysis of PTEN in 344SQ cells after incubation with ApoSQ-exposed CM at various dilutions (from 1/5 to 1) with control CM for 12 h. The qPCR analysis of PTEN mRNA is shown in (c). The immunoblot analysis of indicated proteins in 344SQ cells after the addition of TGF-β1 (10 ng/ml) is shown in (d) and that after the addition of CM is shown in (e). f–l RAW cells were transfected with PTEN siRNA (#1 siPTEN) before ApoSQ cell stimulation for 24 h. f Immunoblot analysis of PTEN in RAW cells. g–l CM was added to 344SQ cells with or without TGF-β1 (10 ng/ml) for the indicated times. g, h, j Immunoblot analysis of indicated proteins in 344SQ cells. i Confocal microscopic images of 3D acini at 12 h after treatment with TGF-β1 (10 ng/ml). Normal acini of 344SQ cells were grown in 3D Matrigel containing CM and stained with anti-β-catenin (green) and DAPI. Scale bars: 20 μm. k qPCR analysis of Snai1 and Zeb1 mRNAs in 344SQ cells. l The numbers of invaded cells were analyzed to assess their invasive ability using Matrigel-coated Transwells. NS not significant; ***P < 0.001. Data are from three independent experiments (mean ± s.e.m. in (c, k, l)) or one experiment representative of three independent experiments with similar results, as shown in (a, b, d–j)
Fig. 3 Internalized PTEN alters signaling, retains polarity, and inhibits the EMT and invasion of 344SQ cells. a Immunoblot analysis of indicated proteins in 344SQ cell lysates after incubation with CM for the indicated times. b Immunoblot analysis of PTEN in 344SQ cells after incubation with ApoSQ-exposed CM at various dilutions (from 1/5 to 1) with control CM for 12 h. The qPCR analysis of PTEN mRNA is shown in (c). The immunoblot analysis of indicated proteins in 344SQ cells after the addition of TGF-β1 (10 ng/ml) is shown in (d) and that after the addition of CM is shown in (e). f–l RAW cells were transfected with PTEN siRNA (#1 siPTEN) before ApoSQ cell stimulation for 24 h. f Immunoblot analysis of PTEN in RAW cells. g–l CM was added to 344SQ cells with or without TGF-β1 (10 ng/ml) for the indicated times. g, h, j Immunoblot analysis of indicated proteins in 344SQ cells. i Confocal microscopic images of 3D acini at 12 h after treatment with TGF-β1 (10 ng/ml). Normal acini of 344SQ cells were grown in 3D Matrigel containing CM and stained with anti-β-catenin (green) and DAPI. Scale bars: 20 μm. k qPCR analysis of Snai1 and Zeb1 mRNAs in 344SQ cells. l The numbers of invaded cells were analyzed to assess their invasive ability using Matrigel-coated Transwells. NS not significant; ***P < 0.001. Data are from three independent experiments (mean ± s.e.m. in (c, k, l)) or one experiment representative of three independent experiments with similar results, as shown in (a, b, d–j)CC BY · PubMed Central
Fig. 4 Downregulation of EMT, the Akt/p38 signaling cascades, and cancer cell invasion by purified exosomes and the exosomal PTEN level in recipient cancer cells. 344SQ cells were treated with exosomes isolated from RAW conditioned medium with (ExoApoSQ CM) or without (ExoCM) apoptotic 344SQ cells, in the presence of TGF-β1 (10 ng/ml) for the indicated times, as shown in (a–d). a–c Immunoblot analysis of indicated proteins in 344SQ cell lysates after incubation with exosomes. d Confocal microscopic images of 3D acini were taken 10 days after cell seeding. The normal acini of 344SQ cells were grown in 3D Matrigel containing exosomes and stained with anti-β-catenin (green) and DAPI. Scale bars: 20 μm. 344SQ cells were treated with purified exosomes from the culture medium of apoptotic cancer cell-stimulated RAW 264.7 cells transfected with or without two siRNAs for PTEN (#1 and #2 siPTEN) for the indicated times, as shown in (e, f). The immunoblot analysis of indicated proteins in purified exosomes is shown in (e), that in 344SQ cell lysates after treatment with purified exosomes is shown in (f). g qPCR analysis of PTEN mRNA in 344SQ cells 12 h after treatment with exosomes isolated from RAW CM with (ExoApoSQ CM) or without (ExoCM) apoptotic 344SQ cells. NS not significant; **P < 0.01. Data are from one experiment representative of three independent experiments with similar results are shown in (a–e, f upper panel), or data from three independent experiments (mean ± s.e.m.) are shown in (f lower panel) and (g)
Fig. 4 Downregulation of EMT, the Akt/p38 signaling cascades, and cancer cell invasion by purified exosomes and the exosomal PTEN level in recipient cancer cells. 344SQ cells were treated with exosomes isolated from RAW conditioned medium with (ExoApoSQ CM) or without (ExoCM) apoptotic 344SQ cells, in the presence of TGF-β1 (10 ng/ml) for the indicated times, as shown in (a–d). a–c Immunoblot analysis of indicated proteins in 344SQ cell lysates after incubation with exosomes. d Confocal microscopic images of 3D acini were taken 10 days after cell seeding. The normal acini of 344SQ cells were grown in 3D Matrigel containing exosomes and stained with anti-β-catenin (green) and DAPI. Scale bars: 20 μm. 344SQ cells were treated with purified exosomes from the culture medium of apoptotic cancer cell-stimulated RAW 264.7 cells transfected with or without two siRNAs for PTEN (#1 and #2 siPTEN) for the indicated times, as shown in (e, f). The immunoblot analysis of indicated proteins in purified exosomes is shown in (e), that in 344SQ cell lysates after treatment with purified exosomes is shown in (f). g qPCR analysis of PTEN mRNA in 344SQ cells 12 h after treatment with exosomes isolated from RAW CM with (ExoApoSQ CM) or without (ExoCM) apoptotic 344SQ cells. NS not significant; **P < 0.01. Data are from one experiment representative of three independent experiments with similar results are shown in (a–e, f upper panel), or data from three independent experiments (mean ± s.e.m.) are shown in (f lower panel) and (g)CC BY · PubMed Central
Fig. 5 Macrophage secretion of 15-HETE, lipoxin A4, and 15d-PGJ2 mediates anti-EMT effects. a–c ELISA of 15-HETE, lipoxin A4 and 15d-PGJ2 in conditioned medium (CM) from RAW cells alone or from cocultures of RAW/viable 344SQ cells (ViaSQ), RAW/apoptotic 344SQ cells (ApoSQ), or RAW/necrotic 344SQ cells (NecSQ). d Time course of PPARγ activation in 344SQ cells with CM or ApoSQ CM at the indicated times. RAW cells were pretreated with 10 μM PD146176 (PD) for 1 h, as shown in (e, h, k), or transfected with two siRNAs against lipocalin-type prostaglandin D synthase (#1 and #2 siL-PGDS) for 48 h, as shown in (f, g, i, j, l, m) before stimulation with ApoSQ cells for 24 h. e–m CM was added to 344SQ cells with TGF-β1 (10 ng/ml) for 48 h. PPARγ activation is shown in (e–g), and the immunoblot analysis of indicated protein expression in 344SQ cells is shown in (h–m). NS not significant; *P < 0.05 and ***P < 0.001. Data are from three independent experiments (mean ± s.e.m.) are shown in (a–g), and data from one experiment representative of three independent experiments with similar results are shown in (h–m)
Fig. 5 Macrophage secretion of 15-HETE, lipoxin A4, and 15d-PGJ2 mediates anti-EMT effects. a–c ELISA of 15-HETE, lipoxin A4 and 15d-PGJ2 in conditioned medium (CM) from RAW cells alone or from cocultures of RAW/viable 344SQ cells (ViaSQ), RAW/apoptotic 344SQ cells (ApoSQ), or RAW/necrotic 344SQ cells (NecSQ). d Time course of PPARγ activation in 344SQ cells with CM or ApoSQ CM at the indicated times. RAW cells were pretreated with 10 μM PD146176 (PD) for 1 h, as shown in (e, h, k), or transfected with two siRNAs against lipocalin-type prostaglandin D synthase (#1 and #2 siL-PGDS) for 48 h, as shown in (f, g, i, j, l, m) before stimulation with ApoSQ cells for 24 h. e–m CM was added to 344SQ cells with TGF-β1 (10 ng/ml) for 48 h. PPARγ activation is shown in (e–g), and the immunoblot analysis of indicated protein expression in 344SQ cells is shown in (h–m). NS not significant; *P < 0.05 and ***P < 0.001. Data are from three independent experiments (mean ± s.e.m.) are shown in (a–g), and data from one experiment representative of three independent experiments with similar results are shown in (h–m)CC BY · PubMed Central
Fig. 6 Antimetastatic effects of UV-irradiated apoptotic cancer cell injections in mice. Apoptotic 344SQ cells (ApoSQ) were subcutaneously injected into the skin lesion 2 days after subcutaneous injection of 344SQ cells into syngeneic (129/Sν) mice (n = 23 per group). Mice were necropsied 6 weeks later. a Representative images of primary tumors (black arrows). Scatter plots of primary tumor weight are shown in (b), and the numbers of metastatic pulmonary nodules are shown in (c). P values were determined by Student’s t test. d Bar graph indicates the number of mice with (w/) or without (w/o) visibly determined metastases (Met). The metastasis incidence P value (Fisher’s exact test). e Representative images of metastatic (left) or nonmetastatic lungs (right). White arrows indicate metastatic pulmonary nodules. The qPCR analysis is shown in (f–j), and immunoblot analysis of indicated protein expression is shown in (k) in primary tumors. *P < 0.05, **P < 0.01, and ***P < 0.001 (Student’s t test). The box represents the 25th to 75th percentile, and the whisker plots represent the minimum and maximum percentiles. Data are from mice with lung metastasis [control; n = 14 in (f–j) or n = 5 in (k)] and without lung metastasis [ApoSQ; n = 8 in (f–j) or n = 5 in (k)] (mean ± s.e.m. in (f–k))
Fig. 6 Antimetastatic effects of UV-irradiated apoptotic cancer cell injections in mice. Apoptotic 344SQ cells (ApoSQ) were subcutaneously injected into the skin lesion 2 days after subcutaneous injection of 344SQ cells into syngeneic (129/Sν) mice (n = 23 per group). Mice were necropsied 6 weeks later. a Representative images of primary tumors (black arrows). Scatter plots of primary tumor weight are shown in (b), and the numbers of metastatic pulmonary nodules are shown in (c). P values were determined by Student’s t test. d Bar graph indicates the number of mice with (w/) or without (w/o) visibly determined metastases (Met). The metastasis incidence P value (Fisher’s exact test). e Representative images of metastatic (left) or nonmetastatic lungs (right). White arrows indicate metastatic pulmonary nodules. The qPCR analysis is shown in (f–j), and immunoblot analysis of indicated protein expression is shown in (k) in primary tumors. *P < 0.05, **P < 0.01, and ***P < 0.001 (Student’s t test). The box represents the 25th to 75th percentile, and the whisker plots represent the minimum and maximum percentiles. Data are from mice with lung metastasis [control; n = 14 in (f–j) or n = 5 in (k)] and without lung metastasis [ApoSQ; n = 8 in (f–j) or n = 5 in (k)] (mean ± s.e.m. in (f–k))CC BY · PubMed Central
Fig. 7 PPARγ and PTEN expression in primary tumors and tumor-infiltrating macrophages. Apoptotic 344SQ cells (ApoSQ) were subcutaneously injected into the skin lesion 2 days after subcutaneous injection of 344SQ cells into syngeneic (129/Sν) mice. Mice were necropsied 6 weeks later. Representative confocal images of primary tumors stained with anti-PPARγ (green) and anti-F4/80 (red) are shown in (a, d); anti-PTEN (green) and anti-F4/80 (red) staining is shown in (e, g); and anti-CD36 (red) and anti-F4/80 (green) staining is shown in (h, j), as well as staining with the DNA-binding dye DAPI. b, c, f, i Measurements of fluorescence intensity in full-size images. d, g, j ROIs from white squares on the low magnification images of (a, e, h), respectively. Arrows indicate the localizations of PPARγ, PTEN, and CD36 in macrophages. NS not significant, *P < 0.05 and **P < 0.01. Data are representative images from five mice per group in (a, e, h) or from independent experiments with five mice per group (mean ± s.e.m. in (b, c, f, i)). Scale bars: 100 μm in (a, e, h)
Fig. 7 PPARγ and PTEN expression in primary tumors and tumor-infiltrating macrophages. Apoptotic 344SQ cells (ApoSQ) were subcutaneously injected into the skin lesion 2 days after subcutaneous injection of 344SQ cells into syngeneic (129/Sν) mice. Mice were necropsied 6 weeks later. Representative confocal images of primary tumors stained with anti-PPARγ (green) and anti-F4/80 (red) are shown in (a, d); anti-PTEN (green) and anti-F4/80 (red) staining is shown in (e, g); and anti-CD36 (red) and anti-F4/80 (green) staining is shown in (h, j), as well as staining with the DNA-binding dye DAPI. b, c, f, i Measurements of fluorescence intensity in full-size images. d, g, j ROIs from white squares on the low magnification images of (a, e, h), respectively. Arrows indicate the localizations of PPARγ, PTEN, and CD36 in macrophages. NS not significant, *P < 0.05 and **P < 0.01. Data are representative images from five mice per group in (a, e, h) or from independent experiments with five mice per group (mean ± s.e.m. in (b, c, f, i)). Scale bars: 100 μm in (a, e, h)CC BY · PubMed Central
Fig. 8 Expression of PPARγ and PTEN and the secretion of PPARγ ligands in isolated TAMs. a qPCR analysis of TAM isolated primary tumors (n = 8). b–d Representative confocal images of TAMs stained with anti-PPARγ (red), anti-PTEN (red), anti-CD36 (red), and anti-F4/80 (green). e ELISA of 15-HETE, lipoxin A4 and 15d-PGJ2 in TAM culture (n = 8). ***P < 0.001 (Student’s t test). Data are from mice with lung metastasis [control; n = 8 in (a–e)] and without lung metastasis [ApoSQ; n = 8 in (a–e)] (mean ± s.e.m. in (a, e))
Fig. 8 Expression of PPARγ and PTEN and the secretion of PPARγ ligands in isolated TAMs. a qPCR analysis of TAM isolated primary tumors (n = 8). b–d Representative confocal images of TAMs stained with anti-PPARγ (red), anti-PTEN (red), anti-CD36 (red), and anti-F4/80 (green). e ELISA of 15-HETE, lipoxin A4 and 15d-PGJ2 in TAM culture (n = 8). ***P < 0.001 (Student’s t test). Data are from mice with lung metastasis [control; n = 8 in (a–e)] and without lung metastasis [ApoSQ; n = 8 in (a–e)] (mean ± s.e.m. in (a, e))CC BY · PubMed Central
Fig. 9 PPARγ-dependent anti-metastatic effects of UV-irradiated apoptotic lung cancer cell injection in mice. a A schematic of the experimental design. Where indicated, GW9662 (1 mg/kg/day, i.p.) or its vehicle (Veh; 2% DMSO in saline) was administered into the left flank 1 day before the injection of ApoSQ into the right skin lesion (n = 5 per group). Mice were necropsied 4 weeks after 344SQ cell injections. b Number of mice with lung metastasis/total number of mice examined. The qPCR analysis is shown in (c), and the immunoblot analysis of indicated protein expression in primary tumors is shown in (d). *P < 0.05, **P < 0.01, and ***P < 0.001 (Student’s t test). Data are representative images from five mice per group (d left) or from independent experiments with five mice per group (mean ± s.e.m. in (c, d right)
Fig. 9 PPARγ-dependent anti-metastatic effects of UV-irradiated apoptotic lung cancer cell injection in mice. a A schematic of the experimental design. Where indicated, GW9662 (1 mg/kg/day, i.p.) or its vehicle (Veh; 2% DMSO in saline) was administered into the left flank 1 day before the injection of ApoSQ into the right skin lesion (n = 5 per group). Mice were necropsied 4 weeks after 344SQ cell injections. b Number of mice with lung metastasis/total number of mice examined. The qPCR analysis is shown in (c), and the immunoblot analysis of indicated protein expression in primary tumors is shown in (d). *P < 0.05, **P < 0.01, and ***P < 0.001 (Student’s t test). Data are representative images from five mice per group (d left) or from independent experiments with five mice per group (mean ± s.e.m. in (c, d right)CC BY · PubMed Central
Fig. 10 A schematic diagram summarizing and integrating the effects of enhanced exosomal PTEN secretion and PPARγ ligands from macrophages exposed to UV-irradiated apoptotic cancer cells to prevent cancer cells from undergoing the EMT and metastatic process
Fig. 10 A schematic diagram summarizing and integrating the effects of enhanced exosomal PTEN secretion and PPARγ ligands from macrophages exposed to UV-irradiated apoptotic cancer cells to prevent cancer cells from undergoing the EMT and metastatic processCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Cited by

See all 45

Metadata

Authors
Kim, Y.-B., Ahn, Y.-H., Jung, J.-H., Lee, Y.-J., Lee, J.-H., & Kang, J. L.
Affiliations
Ewha Womans University (KR)
Corresponding author
Kang, Jihee Lee
Venue
Cellular & Molecular Immunology
Published
2019-03-06
Volume
16
Issue
11
Pages
851-867
ISSN
  • 1672-7681 (ISSN-L)
  • 2042-0226
OpenAlex
W2919429069
Cited by
45
References
69
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 10 · 2019: 5
FWCI
2.90
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Cellular and Molecular Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Research Foundation of Korea (2017R1A2B2004864, 2015R1A2A1A15053112, 2010-0027945, 2010-002794)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
tumor-associated macrophages, lung metastasis, epithelial-mesenchymal transition, PPARγ, PTEN, exosomes, conditioned medium, 15-hydroxyeicosatetraenoic acid, lipoxin A4, SNAI1, ZEB1, tumor cell migration and invasion
MeSH terms
RAW 264.7 Cells, PC-3 Cells, Animals, Humans, Lung Neoplasms, Macrophages, Neoplasm Metastasis, Neoplasm Proteins, Ultraviolet Rays, Apoptosis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Programming of macrophages by UV-irradiated apoptotic cancer cells inhibits cancer progression and lung metastasis. https://app.cochat.ai/papers/10.1038/s41423-019-0209-1
The paper
Kim, Y.-B., Ahn, Y.-H., Jung, J.-H., Lee, Y.-J., Lee, J.-H., & Kang, J. L. (2019). Programming of macrophages by UV-irradiated apoptotic cancer cells inhibits cancer progression and lung metastasis. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-019-0209-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.